Are Peptides Legal in Australia?

The short answer

It depends on the specific peptide. Peptides are simply short chains of amino acids — insulin, semaglutide and teriparatide are peptides and are approved, prescription-only medicines in Australia, while many peptides marketed online for recovery, tanning or body composition have never been assessed by the TGA and are not approved therapeutic goods.

Any article that answers "are peptides legal in Australia" with a single yes or no is wrong. The correct framing is a set of separate questions about a named substance: is it on the ARTG, is it captured by an entry in the Poisons Standard, can it lawfully be supplied to you and by whom, and can it lawfully be imported.

FORM is a pathology testing service. We do not sell, supply, source or recommend any peptide, and nothing on this page is legal advice or an encouragement to obtain anything. Our interest is narrow and practical: if you are already using something, we can measure what your bloods are doing.

The four regulatory questions that actually matter

Australian peptide regulation stacks four separate controls: registration as a therapeutic good, scheduling under the Poisons Standard, lawful supply, and importation. A substance can clear one and fail another.

Because these controls are separate, statements like "it's legal because it's not scheduled" are unsound. A substance can be unscheduled and still be an unapproved therapeutic good that cannot lawfully be supplied or advertised to you.

• Registration (ARTG). Approved medicines have been assessed by the TGA for safety, quality and efficacy and carry an AUST R or AUST L number. Substances that are not on the ARTG have not been assessed and cannot lawfully be advertised or supplied to the public as therapeutic goods.
• Scheduling (Poisons Standard / SUSMP). Scheduling sets access controls — Schedule 4 substances are prescription-only, for example. The TGA has progressively brought a number of research peptides and growth-hormone secretagogues under scheduling entries, and the instrument is amended several times a year.
• Supply. Who may hand the substance to you: a pharmacist against a valid prescription, a practitioner under an approved TGA access pathway, or nobody. Online "research chemical" sellers are not a lawful supply route for human use.
• Importation. Importing unapproved therapeutic goods is separately controlled. The personal importation scheme has conditions and exclusions and is not a general right to import anything; some substances also engage customs prohibited-import controls.

What peptides are legal in Australia?

The peptides that are unambiguously lawful to use in Australia are the ones registered on the ARTG and supplied to you on prescription by a pharmacist for an indication your doctor has assessed.

Insulin is the clearest example — a peptide hormone, an approved medicine, prescription-only. GLP-1 receptor agonists used in type 2 diabetes and weight management are peptides and are approved, prescription-only medicines in Australia, with supply subject to prescribing criteria and, at times, supply shortages managed by the TGA.

The peptides that dominate online searches — recovery peptides, tanning peptides, growth-hormone secretagogues, various "research" compounds — generally sit in a different position: not registered, not assessed, and not lawfully supplied to the public. Some are additionally captured by scheduling.

We deliberately do not publish a "legal peptides list". Any such list is out of date within months, and publishing one edges towards product guidance, which is not our role. The durable advice is: check whether the specific product is on the ARTG, check the current Poisons Standard, and ask a pharmacist if either is unclear.

Who can prescribe peptides in Australia?

Registered medical practitioners can prescribe approved, scheduled peptide medicines within their scope of practice, and can seek access to unapproved peptides for a specific patient through the TGA's Special Access Scheme or by becoming an Authorised Prescriber.

The Special Access Scheme covers access to unapproved goods for a single patient, with different categories depending on the patient's condition and the substance's risk profile. The Authorised Prescriber scheme allows a practitioner to supply a specified unapproved good to a class of patients, subject to approval and reporting obligations. In both cases the responsibility sits with the prescriber, not the patient and not the supplier.

Nurse practitioners and other practitioners with prescribing rights work within their own defined scopes. Compounding pharmacists operate under state and territory pharmacy law, and the TGA has narrowed what may be compounded in several product classes — whether a specific compounded peptide is lawful is a question for the pharmacist and the regulator.

Ahpra's advertising rules also apply to any registered practitioner or clinic advertising these services, which is one reason reputable Australian clinics discuss peptides cautiously and in clinical terms rather than promotionally.

FORM does not prescribe, compound or refer for supply. We provide pathology and interpretation only.

Importing and buying online

Importing unapproved therapeutic goods into Australia is regulated. The personal importation scheme is conditional and carries exclusions, and it does not legitimise every online purchase.

Beyond the legal position there is a practical one that no regulation fixes: products bought from unregulated online sellers have no verified identity, purity, sterility or concentration. Independent testing of grey-market peptide products has repeatedly found mislabelled content and contamination. A blood panel cannot tell you what was in a vial.

We do not link to, name or evaluate suppliers, and we cannot help anyone obtain a substance. If you are considering it, the conversation to have is with a doctor and a pharmacist, not with a vendor.

If you are already using a peptide: what bloods matter

The pathology that matters is a baseline, a repeat at around 8–12 weeks, and periodic monitoring of the organ, metabolic and inflammatory systems most likely to register a problem.

Testing does not make an unapproved substance safe and we do not present it that way. It gives you and your GP objective numbers instead of guesswork, and it makes a later abnormal result interpretable.

• Full blood count — anaemia, infection, platelet changes.
• Liver function tests — ALT, AST, GGT, ALP, bilirubin, albumin, read as a trend against your own baseline.
• Kidney function and electrolytes — creatinine, urea, eGFR, sodium, potassium.
• Fasting glucose and HbA1c — glucose handling is affected by several peptide classes.
• Full lipid profile — total cholesterol, LDL-C, HDL-C, triglycerides, non-HDL-C.
• hs-CRP — systemic inflammation; only interpretable when you are well.
• IGF-1 — where growth-hormone or growth-factor pathways are relevant, against age- and sex-specific intervals.

Where to get these markers tested in Australia

All of the monitoring markers above are available through FORM's Australian panels or as individual add-ons in the panel builder, collected at accredited (NATA / ISO 15189) pathology centres.

FORM Australia is in pre-sale. Join the waitlist and we will email you as soon as ordering opens; prices shown are indicative and final at launch.

• FORM Australian blood test panels — the four core panels and what each includes.
• Build your own Australian panel — add hs-CRP, IGF-1, ESR or iron studies to a base panel.
• BPC-157 in Australia — regulatory position and the specific monitoring panel.
• Peptide monitoring bloods — marker-by-marker rationale and monitoring intervals.
• Testosterone test in Australia — how androgen status is measured and interpreted.